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ABSTRACT-In the Basel study (BS) (1960-73) on cardiovascular
and peripheral arterial diseases, a mortality follow-up was com-
pleted for the period 1965-80. Of the 4,224 men at risk for these
diseases, 531 died. The causes of death were established from the
death certificates and classified into 8 groups. For each case 2 age-
and sex-matched controls were selected and compared with the
corresponding cases with regard to the various variables obtained
at the three examinations (1960, 1965, 1971). This report dealt with
cancer mortality, plasma lipids, plasma vitamins, alcohol and
cigarette consumption, and intake of milk and citrus fruits. The
results were all obtained at the second follow-up examination (BS
Ill, 1971-73). Cancer of the lung, stomach, large bowel, and all
other sites were treated separately. The average follow-up from BS
III until death varied from 3.7 years (other sites) to 4.9 years (cancer
of the lung). Of 129 cancer deaths, the highest incidence was found
for cancer of the lung (38) followed by stomach (19) and large
bowel, (15) and the remainder (57) was for other sites. Plasma lipids
did not differ significantly among cases and controls. However, the
lowest values were observed in colorectal cancer and gastric
carcinoma (mean cholesterol, 213 mg/dl). J3-Carotene was signifi-
cantly lower in cancer cases of the lung than in controls (14.8 I-lg/dl
vs. 23.7; P<.05). It was also low in gastric cancer cases (13.0 I-lg/dl).
Vitamin A was below average only in cases with gastric cancer
(difference due to the small number not significant). Vitamin C was
consistently lower in cancer cases than in controls. The lowest
value was found for cancer of the stomach and corresponded to a
below-average consumption of citrus fruits. Vitamin E was low in
cancer of the colon. Plasma lipids correlated strongly with vitamin E
(r=0.5) and to a lesser extent with vitamin A (r=0.25). J3-Carotene
correlated poorly with J3-lipoproteins (Iow-density and very low-
density Iipoproteins) but significantly with total cholesterol.
Smoking was inversely related, as was alcohol consumption, to the
J3-carotene level. From these results, the conclusion was that
vitamins influence carcinogenesis in humans.-JNCI 1984;
73:1463-1468.
The mortality from many diseases has changed pro-
foundly during the past decades. This finding holds true
not only for infectious diseases but also for chronic
diseases, such as cardiovascular diseases (l) and some
cancers. In particular, cancer of the stomach has declined
whereas the incidence of cancer of the lung is still
increasing in Switzerland (2), and a lesser increase in
carcinoma of the large bowel still is observed in males.
These changes are obviously related to environmental
factors operating through mechanisms of atherogenesis
or carcinogenesis, which are at best only partly known at
present.
Epidemiologic research has clearly established the
concept of cardiovascular risk factors. Modification of
risk factors can subsequently change disease incidence (3,
4). Some risk factors for cardiovascular disease, such as
cigarette smoking, correlate also with cancer. Others,
such as hypertension, do not appear to contribute
substantially to cancer risk. Intriguingly, plasma cho-
lesterol is related in a complex way to cancer: A low
cholesterol concentration appears to increase the risk of
cancer of the colon (5), whereas eating habits that
maintain high plasma cholesterol values correlate with
the incidence of cancer of the large bowel (6).
It was shown recently that low vitamin A and f3-
carotene plasma concentrations predict certain cancers,
and a correlation between low vitamin A levels and
stomach cancer has been suspected for several years (7,8).
The mortality follow-up of the BS (9) allows us to
address these questions because in the last follow-up
examination (1971-73) a survey was made of certain
eating habits as the plasma vitamin concentrations were
measured. The BS began in 1960 with particular em-
phasis on peripheral vascular disease. Healthy em-
ployees, 15-60 years of age, of the pharmaceutical and
chemical companies in Basel were recruited. In the base-
line examination (1960-62) 4,858 men and 1,471 women
took part. The cohort was re-investigated in 1965 (BS 11)
and 1971 (BS Ill). A complete mortality follow-up from
1965-80 was completed recently (l0).
For mortality follow-up, the decision was made to
include only the cohort that participated in the second
and/or third follow-up examination because of a sub-
stantial drop-out after the base-line examination and,
more importantly, to exclude persons already afflicted by
disease. Due to few cases among women, the analysis was
restricted to the male cohort only. In this report the
results pertinent to cancer, vitamins, and serum lipids are
presented.
The BS is the only prospective Swiss study in which
data on risk factors, vitamins, and mortality are available.
Despite the selection introduced by voluntary participa-
tion, a comparison of causes of death shows that the
ABBREVIATIONS USED: BS=Base! study; HDL=high-density lipoprotein;
OD=optical density.
1 Presented at the Vitamin A and Cancer Prevention Conference
sponsored by the Malnutrition Panel, U.S.-Japan Cooperative Medical
Science Program of the National Institute of Arthritis, Diabetes, and
Digestive and Kidney Diseases, and the National Cancer Institute on
February 28-29, 1984, at the National Institutes of Health, Bethesda,
Md.
2 Supported in part by a grant from the regional Krebsliga beider
Base!.
3 Geriatric Clinic, Kantonsspital, 4031 Base!, Switzerland.
4 Department of Physics, University of Base!, 4000 Base!'
5 Department of Vitamin and Nutrition Research, F. Hoffmann-La
Roche & Co. Ltd., 4002 Base!'
6 We thank Dr. Salkeld, F. Hoffmann-La Roche & Co. Ltd., for his
assistance in the preparation of the manuscript and Mrs. H. Nann for
her secretarial work.
1463 JNCI, VOL. 73. NO. 6, DECEMBER 1984
1464 Stiihelln, Rosel. Buess, and Brubacher
METHODS
TABLE 1.-BS mortality follow-up (men only)
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relative distribution of cancer and cardiovascular disease
is comparable to that of the total Swiss population (l0).
Thus our findings are representative for a male Swiss
urban industrialized population. However, the total
mortality was one-third lower than that of the Swiss
population of the same age.
RESULTS
Grouping.-According to the cause of death, 4 cancer
groups were formed: cancers of the lung, the stomach, the
large bowel, and other sites. In the last group the
incidence of the different tumors was too small to allow
detailed analysis.
Clinical and laboratory data.-The variables used in
this report are listed in table 3. With the exception of
smoking, all reported data were obtained at BS Ill. Blood
samples were drawn in the morning after an overnight
fasting period. Lipids and vitamins were immediately
measured. The laboratory methods used were detailed
elsewhere (9). Venipuncture occurred on a voluntary
basis. Thus not all participants had laboratory data.
Comparison of the various data in the different groups
and controls was done with standard statistical pro-
cedures. Statistical significance for differences between
group means was assessed with the Bonferroni test, i.e.,
after adjustment for the multiple comparison of all pairs
of means. The X2 test was used to examine significance
between different frequencies, and correlations were
analyzed with Kendall's coefficient of rank correlation.
Age and Frequency of Cancer Death
Here, only the participants at BS III were considered.
The average age at death did not differ significantly
among the 4 cancer groups (table 4). The colorectal
cancer group was, on the average, the oldest. The shortest
observation period was in the group for other cancer sites
(table 4). Cancer of the lung was by far the most common
carcinoma. Interestingly, 13 cases of carcinoma of the
pancreas were found. This tumor thus was fourth in
rank. Malignant disease at other sites was observed less
frequently and was included with pancreatic carcinoma
in group 4.
Cardiovascular Risk Factors
Mean blood pressure was consistently higher in the
tumor groups than that in the corresponding controls. In
group 4 (various cancer sites) the difference was reached
in statistical significance for BS 11 by the Bonferroni test
(significance level, 0.05; P<'0009). This observation held
true for the BS III values; however, the difference was
smaller.
315
185
Autopsy
531
322
Death
4,224
3.756
Population
at risk
Investi-
gation
BS II: 1965
BS Ill: 1971
Mortality follow-up.-For analysis of the mortality
among the BS cohort over the period 1965-80, the living
status was established for all participants who took part
in the second (1965-67, BS 11) and/or the third investiga-
tion (1971-73, BS Ill). A complete follow-up was possible
on all 4,224 men at risk for cardiovascular and peripheral
arterial diseases. The causes of death were established
according to the death certificates. The cancer registry?
and autopsy data? (table I) allowed an additional control
of the death certificate. The death certificate was cor-
rected according to the autopsy and cancer registry data.
In instances where a tumor coexisted but death occurred
due to a cardiovascular cause or other causes, these cases
were classified with the cancer group. The grouping used
for analysis of the data is shown in table 2.
Selection of controls.-For each case, 2 age- and sex-
matched controls who were still living in 1980 were
selected by a random procedure from the BS 11 file. The
data of the controls were compared with those of the
mortality group as shown in table 2. The number of cases
with data in BS III was smaller since several were already
deceased or did not take part in the follow-up examina-
tion. However, also in the control cohort a drop-out was
noted. The numbers of cases and controls with data: in BS
HI are given in table 2.
TABLE 2.-BS mortality follow-up
With data in BS III
Causes of death ICD-8a No. Total cases
Cases Controls
Cancer site
1. Lung
2. Stomach
3. Colorectal
4. Other sites
All other death causes
Total
162
151
153-154
140-239 (excluding 1-3)
0-999 (excluding 1-4)
62
23
20
91
335
531 (12.57%)
38
19
15
57
193
322 (8.57%)
108
37
33
143
579
900 (21.3%)
a International Classification of Diseases. Eighth Revision.
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"Values are means ± SD.
TABLE 4.-Age at death. age at BS Ill.
and average follow-up period
significance was not reached. Again, the control group
had higher ,B-carotene values (table 5).
Surprisingly, the vitamin A level was comparable in
lung cancer cases and controls. The lowest value was
observed in the gastric cancer group; despite the fact that
the corresponding controls had similarly low lipid levels,
their vitamin A concentration (and ,B-carotene) was
distinctly higher (table 5).
Vitamin E was low in carcinoma cases of the stomach
and large bowel. The values were concordant to the
plasma lipid concentration in the different groups.
Vitamin C was consistently lower in the tumor groups
than in the corresponding controls. The lowest concen-
tration was observed with gastric carcinoma. At the time
of the BS Ill, for which vitamin concentrations were
measured, smoking did not differ significantly between
cases with gastric cancer and controls.
Kendall's coefficient of rank correlation between lipids
and vitamins (table 7) demonstrated the importance of
considering the lipid concentration in evaluating the
vitamin status. More than a quarter of the observed
variances of vitamin E were explained by differences in
,B-lipoproteins. For vitamin A, cholesterol and ,B-lipopro-
teins contributed about 5% each to the observed varia-
bility. An interesting discordant behavior was detected
for ,B-carotene, which apparently correlated significantly
with total cholesterol but only poorly with ,B-lipo-
proteins.
To assess whether additional variables influence the
vitamin status, we analyzed alcohol, milk, coffee, and
citrus fruit consumption and cigarette smoking in
correlation to vitamins and plasma lipids. High ethanol
Average age, yr," at: Average No. of yr
Death BS III for follow-up
4.9
4.2
4.1
3.7
67.5±5.9 62.6±5.9
65.1±7.6 60.9±7.5
68.6±5.8 64.5±5.4
65.9±7.7 62.2±6.9
Cancer site
Lung
Stomach
Colon and/or rectum
Other sites
"LDL=low-density lipoproteins; VLDL=very low-density lipo-
proteins.
TABLE 3.-Variables considered
Primary cause of death (death certificate + autopsy)
Age
Blood pressure (mm Hg)
Cholesterol (rng/dl)
Triglycerides (mg/dl)
Total ~-Iipoproteins (estimation of LDL + VLDL in OD)"
Vitamin C (mg/dl)
~-carotene (j.Lg/dl)
Vitamin A (ID)
Vitamin E (rng/dl)
Alcohol consumption (daily, weekly, or less)
Smoking (number of smokers/cigarettes/day)
Milk consumption
Citrus fruits intake
For plasma cholesterol, triglycerides, and ,B-lipopro-
teins, only the BS III values were considered. Stomach
cancer and colorectal cancer groups had the lowest
cholesterol and ,B-lipoproteins. The control group
matched to the cancer of the stomach group happened to
have rather similar plasma lipid values. Lung cancer and
controls also did not differ with regard to their lipid
values (table 5).
Smoking (less than or equal to five cigarettes/day; data
from BS 11) was significantly more prevalent in cases
with cancer of the lung, as well as in cases with cancers of
the stomach and large bowel. A trend for cancer was
observed more in smokers in the group for other cancer
sites than in the control groups. Thus the difference
became again highly significant (table 6). However, if the
cohort that participated in BS III is considered, the
differences would become too small between controls and
cancer groups and the statistical significance would be
lost.
Plasma Vitamins
Vitamins Bj, B2, and B6 were comparable in all cancer
groups and controls. The most striking difference in the
,B-carotene level occurred in the lung cancer group
compared to controls (significance level, P<'05; P-value,
.0006). An even lower concentration was found in the
gastric cancer group. Due to the small number, statistical
TABLE 5.-Plasma lipids and vitamins in cancer cases and controls"
Choles- Trigly- ~-Iipo- Vitamin C, Vitamin A, Vitamin E,Subjects (n) terol, cerides, proteins, ~-carotene,
rng/dl mg/dl OD mg/dl ID j.Lg/dl mg/dl
Lung cancer cases (35) 230±52 157±149 710±233 0.79±0.44 286±77 14.8±9 1.5±0.46
Controls (102) 232±41 142±85 720±222 0.90±0.43 280±62 23.7±15.6h 1.7±0.52
Stomach cancer cases (19) 213±42 124±67 640±251 0.72±0.42 246±54 13.0±8.8 1.5±0.58
Controls (37) 215±36 132±68 650±188 0.93±0.35 274±48 19.4±9.4 1.5±0.31
Colon and/or rectum cancer cases (14) 213±38 126±62 615±226 O.77±O.43 284±57 20.1±20 1.4±0.36
Controls (33) 236±35 141±70 720±221 O.78±0.40 277±43 25.6±17 1.6±O.48
All other cancer site cases (47) 218±43 137±114 643±174 0.84±O.40 271±74 18.3±11.2 1.6±O.43
Controls (136) 220±38 133±103 670±224 O.90±O.39 273±61 20.7±12 1.6±O.41
"Values are means ± SD.
h Significance level, <'05; Bonferroni test.
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TABLE 6.-Smoking and cancer: Data/ram BS Il TABLE 8.-Correlation between lipide, vitamins. and life style·
Smoker Nonsmoker 2 Consumption of:Subjects X
Lung cancer cases 44 18 P=.OOOI Nutrients Smoking ofControls 40 73 Alcohol Milk Coffee Citrus cigarettes/
Stomach cancer cases 15 8 P=.005 dayControls 12 30 Vitamin C -0.03 -0.05 -0.09 0.27 -0.03Colorectal cancer cases 10 5 P=.005 f3-Carotene -0.11 0.00 -0.06 0.11 -0.09Controls 8 26 Vitamin A 0.12 -0.19 0.03 -0.04 0.02Other cancer site cases 43 48 Not significant Vitamin E 0.02 -0.12 0.00 -0.06 -0.04Controls 80 81 Cholesterol 0.02 -0.10 0.02 -0.11 0.02Total cases 112 79 P=.OOOI f3-Lipoproteins 0.02 -0.15 0.08 -0.08 -0.01Total controls 140 210
• Kendall's coefficient of rank correlation.
TABLE 7.-Correlation betll'een plasma lipids and vitamins·
DISCUSSION
Of all deaths observed in the male cohort of the BS, 40%
had cancer and in 35.2% the primary cause of death was
considered to be cancer. The total mortality was lower
than that of the Swiss population of similar age, but the
relative contribution of the main causes did not differ
(l0). Thus our cohort seems to be representative for a
Swiss urban working population. The single most
important cause was cancer of the lung followed by
cancer of the stomach and large bowel. In Switzerland, as
in most industrialized Western countries, cancer of the
lung increased from 20 to 200/100,000 between 1921 and
1974 in the age groups 50-69 years (2). During the same
period, cancer of the stomach declined from over 200 to
consumption correlated weakly with vitamin A (table 8).
In any case, alcohol seemed to influence ~-carotene and
vitamin A in opposite ways. Surprisingly, we observed an
inverse (albeit weak) correlation among milk consump-
tion, plasma lipids, and fat-soluble vitamins. However,
we found a strong direct correlation between the con-
sumption of citrus fruits and plasma vitamin C. The
inverse correlation between number of cigarettes per day
and ~-carotene might have importance. No consistent
differences were reported for consumption of coffee and
vegetables.
With the exception of colorectal cancer, more cancer
cases drank ethanol daily than did controls. The dif-
ference was most pronounced in cancer of the lung (X2,
P=.07) and was significant for all cancer cases together
(P=.02). If we compare the consumption of citrus fruits in
the different cancer groups and controls, we find in the
gastric cancer group with the lowest vitamin C concen-
tration no individual with high citrus fruit intake. Citrus
fruits were eaten less than three times weekly by 79% of
the cases and by 54% of the controls.
a Kendall's coefficient of rank correlation.
approximately 40/100,000 in the same age group. In the
higher age group the decrease is slightly less. As shown
by Doll and Peto (6) these changes occurred in a similar
fashion between the years 1950 and 1976 in many
different industrialized countries.
In view of the long, silent period of cancer develop-
ment, mortality changes reflect changes in carcinogenesis
dating far back before the actual event recorded as cancer
death takes place. Furthermore, the epidemiologic study
period 1965-80 covers the time in which dynamic
changes of incidence did occur. Thus observations in the
latter part of our study probably mean something
different in regard to future events than to events rather
close to the recording period. This possibility was
observed by the International Collaborative Group on
cholesterol level and risk of death from cancer (11). Age
itself will lower differences, as observed with our results
on smoking. At BS 11 the difference between the cancer
groups compared to the controls was significant. At BS
III (in an albeit smaller number) the difference is less
impressive and loses statistical significance.
Accurate death certificates have crucial importance.
The availability of a cancer registry and the autopsy rate
of over 60% allowed a careful assessment. In the non-
autopsied cases, a 5% cancer rate seems likely if we
extrapolate from our autopsy material (Stahelin HB,
Hiisser A, Buess E: Manuscript in preparation). Thus the
true incidence of malignant diseases remains slightly
higher than the incidence reported in this study. Since we
are mainly interested in cancer, it seems justified to
consider as cancer cases also those subjects who died from
another disease but had cancer in addition.
The total number of cancer cases considered in our
study seems large. Most individual cancers occurred,
however, so infrequently that treating them as separate
groups seemed meaningless. Therefore, only cancers of
the lung and of the stomach and large bowel were treated
separately. In the comparison of small groups and
numerous variables, the selection of controls becomes a
central issue. In an initial analysis of some of our results,
we compared cases to the total living cohort of similar
age (12). Due to the large number of subjects, statistical
significance at the 5% level was reached for numerous
variables. That this procedure has the danger of the
highest error becomes evident when one considers the
0.45
0.51
Vitamin
E
0.21
0.25
Vitamin
A
0.21
0.07
f3-carotene
0.01
0.{)1
Vitamin
CLipids
Cholesterol
f3-Lipoproteins
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results of the control groups drawn at random. The
random selection of controls matched by age and sex to
cancer cases of the stomach surprisingly yields subjects
with below-average lipid levels.
The observed significantly lower l3-carotene concen-
tration after adjustment for all other tested variables in
cancer of the lung is in agreement with reports of
Shekelle et al. (13) and in other studies reviewed
elsewhere (5-7). Vitamin A, which was found by Wald et
al. (14) to be lower in cancer cases of the lung, did not
differ among cases and controls in the BS findings that
were similar to the findings reported by Willet et al. (15).
Cancer of the stomach was associated with lower vitamin
A levels, again in keeping with other studies (8, 16, 17).
In contrast to most other studies in this field, we
emphasize that vitamin analysis was performed immedi-
ately after blood sampling, which eliminated problems of
storage and degradation.
As pointed out above, the cholesterol and l3-lipo-
protein levels were comparable in the cancer cases and
controls. The different levels among the subject groups
probably reflect different nutrient intake or the in-
fluence of other variables. In this context, the influence of
smoking has to be considered. Smoking correlates with
low vitamin C. Furthermore, smoking, especially the
number of cigarettes smoked, correlates inversely with
the l3-carotene concentration. An influence of smoking
on carotene was also observed by Davies et al. (18).
However, l3-carotene correlates significantly with total
cholesterol but not with 13-lipoproteins. This finding
suggests a correlation with HDL-cholesterol not
measured in our population. Smoking too is known to
decrease HDL concentration. Investigators in other
studies observed a significant correlation with HDL-
cholesterol and carotene levels (19, 20). The weak inverse
correlation between alcohol consumption and l3-carotene
blood levels may be due to the alcohol-cancer association
observed in our study and recently in Japanese men in
Hawaii (21).
The relatively short follow-up period in our cohort
suggests that an effect of l3-carotene might still be
operating at a late stage of carcinogenesis (6). The
discordant findings of low carotene and normal vitamin
A in cancer of the lung are somewhat contradictory and
not easily explained. Probably, the differences in alcohol
consumption and smoking contribute to the discordant
findings, since vitamin A correlates more strongly with
13-lipoproteins than does l3-carotene, as discussed above.
The consistently lower vitamin C concentration in all
cancer groups is intriguing. The lowest values were
observed in the gastric cancer group. In this group,
intake of citrus fruits, which correlates strongly with
plasma vitamin C, was markedly lower. In 1964 Meinsma
(22) already found a low intake of citrus fruits in cases of
gastric cancer. Thus one finds a tempting speculation to
be that vitamin C prevents development of gastric cancer
by its inhibiting the formation of N-nitroso compounds
(23). On the basis of our results and the small number of
events, we are not able to differentiate diffuse carcinoma
and the so-called intestinal type carcinoma, which differ
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in many respects (24). Nevertheless, epidemiologic and
experimental evidence points to the fact that adequate
vitamin C ingestion may diminish the risk of cancer of
the stomach and large bowel (25, 26).
Cancer cases of the large bowel had vitamin A and
l3-carotene levels comparable to the levels for controls,
despite the low blood lipids. The correlation among
lipids and vitamin E explains the low vitamin E
concentration in the large bowel cancer group. Several
other studies reviewed in detail elsewhere (2, 27) showed
average cholesterol levels in cancer patients, with the
notable exception of those for cases with subsequent
cancer of the colon who had significantly lower lipid
levels. The association of lipid-soluble vitamins with
plasma cholesterol and l3-lipoproteins still could yield a
clue to the observation that societies with high meat and
fat intake and low plasma lipids might be less well
protected from a variety of mutagenic compounds com-
pared to subjects with higher lipid levels under a similar
nutrition and high lipid and vitamin levels as suggested
by Dion et al. (26).
The findings of the BS clearly demonstrate the influ-
ence of several factors on carcinogenesis. Nevertheless,
our results and the consistency of the epidemiologic and
experimental evidence support the concept that
carotenes, vitamin E, and vitamin C affect the develop-
ment of certain cancers.
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